Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02005016 · ClinicalTrials.gov registry record · NA
Dosage and Predictors of Naming Treatment Response in Aphasia
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02005016: Completed NA study, sponsored by VA Office of Research and Development.
NCT02005016 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02005016, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study examines aphasia treatment response among Veterans and non-Veterans living with aphasia. It seeks to identify cognitive and neural factors which are predictive of positive response to treatment targeting naming impairments in aphasia. It also examines the dose-response relationship for naming treatment. More broadly, it seeks to determine who aphasia therapy works best for, and how much aphasia therapy is sufficient to achieve positive treatment response.
Interventions
- BEHAVIORAL Naming therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02005016
The ClinicalTrials.gov registry entry for NCT02005016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naming therapy is the first listed.
NCT02005016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02005016 about?
NCT02005016 is a clinical study titled "Dosage and Predictors of Naming Treatment Response in Aphasia". This study examines aphasia treatment response among Veterans and non-Veterans living with aphasia. It seeks to identify cognitive and neural factors which are predictive of positive response to treatment targeting naming impairments in aphasia. It also examines the dose-response relationship for na...
What is the current status of trial NCT02005016?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2013-10-01. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02005016?
The interventions under investigation include: Naming therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02005016?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.